Matt Wade
Matt supports the Biopharma Journal Finance editorial team with reporting, research, and audience development. He was previously with WallStreet International in NYC.
Recent Post
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,...
Many experts suggest that we're currently experiencing a renaissance in biotechnology. The field is undergoing revolutionary transformations, unlocking novel methods to combat...
